Family Court · Forensic Testing Guide

Drug & Alcohol Testing in Family Court: A Guide to Choosing the Right Test

There is no single best test. Each one is the best at the job it was built for — and a result only helps a court if it was collected correctly and read for what it actually shows. A guide to matching the test to the question.

When a court orders drug or alcohol testing in a custody or parenting matter, the choice of test is rarely as simple as "get a drug test." Different tests answer different questions, look back over different windows of time, and carry very different evidentiary weight. A test that is perfect for proving long-term sobriety may be useless for catching a single episode of use — and a result that seems damning may not hold up at all if the wrong type of test was ordered.

I am often asked, "What is the best test?" The answer is not the one people expect: there is no single best test. Each one is the best at the job it was designed to do. Think of them like tools on a tool belt — a hammer is the best tool for driving a nail, but that does not make it the best tool. The skill is in matching the tool to the task.

This guide explains the tests most often used in family court — hair, urine, PEth, sweat patch, and remote video-observed testing — what each one actually proves, and how to match the test to the question your case is asking. It is written for the attorneys, guardians ad litem, and judges who have to make or evaluate these decisions, and for the parents subject to them.

First, the distinction that decides cases: forensic vs. diagnostic testing

Before comparing individual tests, there is a threshold question that determines whether any result will mean anything in court: was the test forensic or diagnostic?

A diagnostic test is what a doctor orders through a patient's health insurance. It is designed to inform medical care, and it is often cheaper — which is exactly why a parent under a testing order may be tempted to use it. But a diagnostic result generally has no documented chain of custody, no tamper-evident specimen handling, and no mandatory confirmation of a positive result. In a contested proceeding, those gaps are fatal.

A forensic test is built from the ground up to withstand scrutiny. Its defining feature is a documented chain of custody that tracks the specimen from the moment of collection to the final reported result — properly collected, sealed, securely transported, and tamper-evident at every step. Combined with mandatory confirmation testing and strict documentation, this is what makes a forensic result defensible if it is ever challenged.

The practical takeaway for counsel: a result is only as strong as the process that produced it. If testing may end up in front of a judge, it needs to be forensic from the first step. A physician-ordered diagnostic test, however convenient, is the wrong tool for a courtroom.

Forensic testingClinical / diagnostic
Chain of custodyRequiredNot required
Specimen securityTamper-evident sealsNo seals required
Confirmation of positivesMandatoryOptional
Specimen transportFormal custody documentationSimple manifest

What makes a forensic result defensible

Three things give a forensic result its evidentiary weight. Understanding them helps counsel know what to ask for — and where to probe an opposing party's result.

Chain of custody. This is a document created at the moment of collection, sealed with the specimen, and sent to the laboratory. It ties the donor to the specimen and records every transfer of custody along the way. It captures the date and time of collection, the donor's name, a unique specimen ID, the type of and reason for the test, the tamper-evident seal, and the signatures of both collector and donor attesting to the authenticity of the collection. If any link in that chain is missing, the result is open to challenge.

Confirmation testing. An initial screen — typically an immunoassay — is fast but imperfect; it can produce a false positive through cross-reactivity with common over-the-counter or prescription medications. For that reason, forensic standards require any positive screen to be confirmed using a different, more precise analytical method, such as gas chromatography/mass spectrometry (GC/MS) or liquid chromatography/tandem mass spectrometry (LC-MS/MS), as required under the SAMHSA Mandatory Guidelines and 49 C.F.R. Part 40. Confirmation does two things: it eliminates false positives, and it quantifies the exact amount of the specific drug present rather than simply flagging a category.

Medical Review Officer (MRO) review. Drug testing grew out of the workplace, where a positive result must be distinguished from the legitimate use of a prescribed medication. That is the MRO's job. When a result is positive for a drug for which the donor holds a valid prescription, the MRO accounts for it (49 C.F.R. § 40.137). One important limit, often misunderstood: the MRO is not attesting that the donor is taking a medication as prescribed — only that the donor has a prescription for the drug that tested positive.

The distinction that may matter most: the laboratory report vs. the MRO report

This is the point least understood by parties in family court, and it can be decisive.

There are two different documents that can come out of a drug test, and they are not the same thing. The laboratory report is what the lab produces: it shows every substance and metabolite detected, with quantitative values. The MRO report is what the Medical Review Officer issues after reviewing that lab result and accounting for valid prescriptions. The MRO report is a summary determination — and by design, it can screen out information that the laboratory report contains.

Here is how that works in the standard workplace process. The lab sends its result directly to the MRO. The MRO contacts the donor, verifies any prescription with the pharmacy, and — if the positive is explained by a valid prescription — downgrades the positive to a negative before reporting out. The employer never learns that a substance was present at all. This is entirely appropriate in employment: under medical-privacy principles, an employer is entitled to know only whether the employee is cleared, not the underlying medical details, and the MRO process exists precisely to protect the employee's legitimate privacy.

But a family court is asking a fundamentally different question than an employer. The court is not deciding fitness for a job; it is weighing a child's safety. In that setting, the gap between the two reports can distort the picture in either direction — and the two distortions cut against opposite parties:

Distortion one

A "negative" can conceal a fact the court needs. Suppose the concern is that a parent is misusing a prescribed controlled substance — a stimulant, or an opioid such as methadone. If the parent holds a valid prescription, the MRO does its job correctly and reports the result as negative. The parent may then offer that negative as vindication: the lab came back negative, so the concern is baseless. But a negative does not mean the substance was absent. It means only that a positive was explained by a prescription. The laboratory report shows what the MRO negative does not: that a powerful controlled substance was in fact present in the parent's system. Whether its presence or amount signals misuse — or whether a parent is functioning under the influence of a powerful drug — is a further question for qualified interpretation, but the court cannot weigh a fact it was never shown. And whether the court ever sees that laboratory report can turn on a question most parties never think to ask: how the testing provider's account is configured. A provider whose core business is workplace testing will typically have its accounts set to report through an MRO — the account holder receives the MRO's pass/fail determination, not the underlying laboratory report. Order testing through that kind of provider in a family-court matter, and you may receive only the MRO report: the laboratory result exists, but it is never released to you, and the fact the court needed is screened out before anyone in the case ever sees it.

Distortion two

The same data can be read to say more than it shows. The error also runs the other way. A positive result, or a particular value on a report, can be presented as proof of something the science does not establish — that a parent "uses every day," is "an addict," or was impaired at a specific moment. A level on a laboratory report is not a frequency of use, a diagnosis, or a measure of impairment, and the methods for estimating any of those from a single result have real limits (American Family Physician 2023; Quest Diagnostics 2023). Treating a number as if it settled those questions — to build a narrative rather than to answer the court's — is its own distortion, and it can do real harm to a parent who is in fact compliant.

The lesson for counsel is not that one report is "better," but that the two answer different questions and neither speaks for itself. The MRO summary tells the court whether a positive was prescription-explained; the laboratory report shows what was actually in the specimen. A court weighing a child's safety is usually best served by understanding both — and by having the underlying findings interpreted by someone qualified to say what they do and do not establish, so the data is neither concealed nor exaggerated. One practical consequence is worth carrying into the order itself: because the two reports are not the same, an order that simply says "release the results" may not produce the laboratory report at all. If the court should see it, the order should ask for it by name.

The tests at a glance

TestWhat it detectsDetection windowSampleBest used to…Key limitation
HairDrugs & metabolites (and EtG for alcohol)~90 days (head hair); up to ~12 months (body hair)HairEstablish a pattern of use over monthsNot designed to catch a single, isolated use; environmental exposure and cosmetic treatment can affect results
UrineDrugs & metabolitesDays (recent use)UrineDetect recent use; run frequent, affordable random programsShort look-back window; easiest specimen to attempt to adulterate
PEthAlcohol (a direct biomarker)~2–4 weeksBlood (fingerstick or draw)Confirm or refute recent alcohol use, including infrequent drinkingAlcohol only; collected from blood
Sweat patchDrugs (continuous)Continuous over the 7–10 day wear periodSweatContinuously monitor between visitsLimited drug panel; no alcohol; application and removal must be done in person
Remote video (oral fluid)Drugs (presumptive)~24–48 hoursOral fluidFrequent, low-cost, real-time monitoringPresumptive only — not court-defensible on its own

The sections below explain the strengths and the honest limitations of each.

Hair testing

Hair is what toxicologists call a reservoir matrix — a biological material that accumulates and retains substances over time. As hair grows, drugs and their metabolites are incorporated into the shaft, creating a historical record of use.

Head hair grows at an average of about half an inch per month, and the laboratory tests the 1.5 inches closest to the scalp — which yields the often-cited ~90-day detection window. Body hair works differently: it grows to a set length and stops, then eventually sheds and regrows, a cycle that can span up to a year. That is why body hair can reflect use over a much longer period — up to roughly 12 months.

Hair's great strength is this long look-back. Because of it, hair testing is the best starting point for establishing whether a pattern of drug use exists. Its corresponding limitation is the flip side of the same trait: hair testing is not designed to detect a single instance of use. A one-time episode may simply not register.

Two honest challenges counsel should understand:

Environmental exposure — and why, in family court, it is not an excuse. A hair result is sometimes challenged on the theory that a positive reflects exposure rather than use: that the donor did not consume the drug, but was simply present where it was around. In many forensic contexts that distinction matters. In family court, where the welfare of a child is the central question, it deserves a harder look — because the distinction may be far less reassuring than it sounds. If a parent or caregiver is consistently in an environment where a drug is present in high enough concentrations to transfer into their own hair, that same environment is one the child may share. A positive explained by environmental exposure is not a clean bill of health; it is, at minimum, evidence of proximity to drugs significant enough to warrant further investigation, not less.

To define the term: environmental exposure refers to the physical transfer of a drug into the hair from a contaminated environment — for example, when a donor is consistently present where a drug is smoked, handled, manufactured, or distributed. The drug transfers from that environment and becomes incorporated into the hair. It is a recognized phenomenon, and a legitimate line of inquiry when a hair result is contested — but in a family-court setting, it raises questions about the child's environment rather than settling them.

Cosmetic treatment. Chemical treatments such as bleaching, coloring, and perming can reduce the measurable content of certain analytes in hair — EtG, the alcohol marker, among them. This matters most when hair is being used to assess alcohol use, and it is one of the reasons we generally prefer a direct blood biomarker (PEth) for the alcohol question.

Urine testing

Urine is the most familiar forensic test, and for good reason: it is highly sensitive to recent use, widely available, and relatively affordable. Those qualities make it the workhorse of random testing programs, where the goal is frequent, unpredictable monitoring rather than a single look-back. Collection sites are abundant nationwide, which makes urine the easiest test to administer to a donor who lives far from any one provider.

Its limitation is the mirror image of hair's. Urine has a short detection window — generally measured in days — so it catches recent use but tells you nothing about the weeks or months before. It is also the specimen most commonly targeted for adulteration or substitution, which is precisely why forensic collection protocols and chain of custody matter so much for urine in particular.

PEth testing — the most precise answer to the alcohol question

When the question is alcohol, PEth (phosphatidylethanol) is, in our practice, the most reliable tool available — and it is the test most often misunderstood by parties who are more familiar with older alcohol markers.

PEth is a direct biomarker: it forms in red blood cells only when ethanol is present in the body. Its presence is therefore specific evidence of alcohol consumption, not an indirect inference that other conditions can confound. It reflects drinking over roughly the past two to four weeks, which makes it well suited to monitoring abstinence — the very question family courts most often need answered.

Why PEth over the alternatives for alcohol?

  • Urine (via EtG/EtS) is highly sensitive but has a short window — it can miss drinking that occurred outside a narrow recent period.
  • Hair (via EtG) offers a long window but is poorly suited to detecting infrequent or single-episode drinking, and, as noted above, its EtG content can be reduced by cosmetic hair treatment.
  • PEth is sensitive to infrequent drinking and covers a multi-week window, and because it is measured in blood it is not affected by hair cosmetics.

To make the contrast concrete: this is not a hypothetical. In one case, we collected a PEth blood sample and an EtG hair sample from the same donor on the same day — the PEth returned positive while the hair returned negative. That is not a contradiction; it is exactly what the science predicts when drinking is recent or infrequent: PEth's sensitivity detects it, while the hair test — less suited to isolated use, and potentially affected by cosmetic treatment — does not. The lesson for counsel is that choosing the wrong alcohol test can produce a falsely reassuring negative.

The one practical consideration with PEth is that it is collected from blood — either by a simple finger-stick dried blood spot or by venipuncture, depending on the laboratory used. Because the finger-stick option is minimally invasive and widely supported, PEth can be collected at a broad range of sites and arranged almost anywhere through national laboratory networks (more on ordering below).

Sweat patch and remote video testing

Two further methods round out the toolkit. Both are valuable in the right case, and both carry limits that counsel should state plainly.

Sweat patch testing provides continuous monitoring. Metabolites are excreted in sweat, and the patch collects them over a wear period of 7–10 days. The donor returns to have the patch removed and a fresh one applied, and the cycle continues for as long as monitoring is required — which makes it a strong alternative to frequent random urine testing for ongoing supervision. Its limitations are a limited drug panel, no alcohol detection, and the fact that application and removal must be performed in person. Because of that, it is arranged through a TrueTest collection location or a scheduled mobile collector who handles both the application and the removal, rather than as a walk-in.

Remote video-observed testing uses an oral-fluid device read live during a video session. Its appeal is convenience and frequency: donors test from home, there is no collection-site trip and no separate collection fee, results read immediately, and the low cost makes frequent monitoring practical. The critical caveat is that these results are presumptive only — not laboratory-confirmed, and not court-defensible on their own. Oral fluid also has a shorter window (roughly 24–48 hours) than urine.

That limitation has a built-in remedy, however: a presumptive positive can escalate to litigation-grade evidence. When the live screen flags a positive, it triggers a chain-of-custody confirmation — a urine specimen collected at a site or by a mobile collector, sent to the laboratory, and returned as a confirmed, court-defensible result. Used this way, remote video testing is best suited to ongoing monitoring under agreed parenting plans or consent orders, and to early detection and accountability — not as a standalone substitute for laboratory testing.

How to choose: matching the test to the question

To return to the tool-belt: the right test is simply the one built for the job in front of you. The right test follows from the question the case is actually asking.

  • "Is there a pattern of drug use over months?" Start with hair. Its long window is built for establishing patterns.
  • "Is the parent using drugs right now / recently?" Urine, ideally in a random program for ongoing assurance.
  • "Is the parent drinking, including occasionally?" PEth. It is the most sensitive and specific answer to the alcohol question, and it covers a multi-week window.
  • "We need continuous drug monitoring between visits." Sweat patch (where in-person application is feasible).
  • "We want frequent, low-cost monitoring with court-defensible backup." Remote video, with automatic chain-of-custody confirmation of any positive.

In many cases the strongest approach combines methods — for example, hair to establish a baseline pattern, plus PEth or random urine for ongoing monitoring. The goal is to choose the instrument that answers your question, rather than defaulting to the most familiar test.

Because every case turns on its own facts and goals, this is also where outside guidance helps most. We regularly consult with attorneys and guardians ad litem to review the specifics of a matter — what the court is trying to establish, the detection window that fits, the panels that make sense — and to recommend a testing approach built for that case. If you would like to talk through the right tool for the job before drafting an order, schedule a call with us to review the specifics.

The collection site is the easy part — the difference is what surrounds it

A common misconception is that court-ordered testing requires the parties to live near the testing provider. They do not. Through national laboratory and collection networks of more than 10,000 sites, we order and coordinate forensic testing for donors almost anywhere in the country.

The process is straightforward. We create the electronic order and email the donor a "passport" — a form carrying our account information, the assigned collection-site details, and a barcode. The donor provides a zip code, and a list of nearby collection sites appears — typically several within about 15 miles, including nationally branded occupational-testing centers, hospitals, urgent-care clinics, and independent collection sites. The donor simply goes to a chosen site, presents government-issued photo ID, and provides the sample. The site scans the barcode to pull up the order, collects under proper chain of custody, and ships the specimen to the partner laboratory. For PEth and other blood-based testing, the passport routes the donor to a site that performs blood draws through national networks such as LabCorp, or to USDTL-partnered sites.

That convenience is real — but it is also the part every provider can offer, and it is where most people stop thinking. The collection itself is largely standardized: a qualified site will collect the sample properly under chain of custody almost anywhere. The difference between providers is not the collection. It is everything around it:

  • Is the account configured to release the laboratory report, or only an MRO determination? As noted above, a provider built for workplace testing will often return only the MRO's pass/fail — and in a family-court matter, that can mean the court never sees the underlying result.
  • Does the provider understand what the results actually say? What a PEth value does and does not establish, the look-back of a hair test and its real limitations, what a given panel covers — this is what determines whether a result is read correctly or oversold. Collecting the sample does not require that knowledge; using the result in court does.
  • Can the provider run the program the case needs? If the matter calls for ongoing random testing rather than a single result, that takes a real randomization program, not just a one-time appointment.

With TrueTest Labs, those questions are already answered — accounts set up so the full laboratory report is available rather than withheld behind an MRO-only determination, working knowledge of what each test means and where its limits lie, and random-program capability when a case needs it — while collection still happens at the most convenient vetted site for the client. Analysis is performed by nationally accredited partner laboratories, including Quest Diagnostics, Clinical Reference Laboratory (CRL), LabCorp, and United States Drug Testing Laboratories (USDTL). The site near you handles the sample; what surrounds it is what makes the result usable in court.

A note on legal DNA (parentage) testing

Although this guide focuses on drug and alcohol testing, parentage questions also arise in family court — and here too the forensic distinction matters. A consumer or at-home DNA kit is not built for court. Court-admissible DNA testing requires the same chain-of-custody discipline as forensic drug testing: identity-verified collection, tamper-evident handling, and documented custody from collection through the accredited laboratory. TrueTest Labs arranges legal DNA/parentage testing nationwide through the same passport model described above. Because parentage testing raises its own considerations, it is addressed separately — but the governing principle is identical: if a result may go before a judge, it must be collected forensically from the first step.

A model testing order for the court

One of the most practical steps counsel can take is to use a testing order that is written for forensic testing from the outset — one that appoints the collection provider, specifies the panels, sets the random-testing parameters, addresses specimen integrity (for example, prohibiting hair cutting or coloring before a hair test), and directs the release of complete results to the parties, the GAL, and the court.

TrueTest Labs makes a fillable model order available for this purpose, in both an editable Word version and a print-ready PDF. Counsel are encouraged to adapt it to the requirements of their jurisdiction and the facts of their case, in consultation with the court.

A plain-language guide you can give your client

Whether a test turns out to be useful often comes down to what your client does before the laboratory is ever involved — going to a provider equipped for court work, taking the test that fits the question, and doing it before the window closes. To help with that, TrueTest Labs offers a short companion guide written for parents: Ordered to Take a Drug or Alcohol Test? Read This First. In plain language, and without taking either side, it explains why a court-ordered test is different from a routine clinic visit, why a result has to be collected correctly to count for anything, and why acting promptly matters. Counsel are welcome to share it with clients directly — it is built to head off the avoidable mistakes that produce a result the court cannot use.

A note on getting it right the first time

Court-ordered testing is often a single opportunity to answer a consequential question. A test ordered through the wrong channel, or matched to the wrong question, can produce a result that is either inadmissible or misleading — a diagnostic test with no chain of custody, an alcohol test that misses recent drinking, a hair test asked to catch a one-time use it was never designed to detect. And the cost of a wrong choice is not only a weak result; it can be a question that becomes impossible to answer. Detection windows close — substances clear the body, hair grows out — and the moment that would have answered the question may not come again. The tests themselves are reliable when chosen and handled correctly; the expertise is in matching the method to the question, and in getting the process forensically sound from the first step, while the answer is still there to be found.

References

Scientific literature

  • Boumba, V. A., Ziavrou, K. S., & Vougiouklakis, T. (2006). Hair as a biological indicator of drug use, drug abuse or chronic exposure to environmental toxicants. International Journal of Toxicology, 25(3), 143–163.
  • Henderson, G. L. (1993). Mechanisms of drug incorporation into hair. Forensic Science International, 63(1–3), 19–29.
  • Jones, J., Jones, M., Plate, C., & Lewis, D. (2011). The detection of 1-palmitoyl-2-oleoyl-sn-glycero-3-phosphoethanol in human dried blood spots. Analytical Methods, 3(5), 1101–1106.
  • Kerekes, I., & Yegles, M. (2013). Coloring, bleaching, and perming: influence on EtG content in hair. Therapeutic Drug Monitoring, 35(4), 527–529.

Clinical and laboratory references

  • Phosphatidylethanol test for identifying harmful alcohol consumption. American Family Physician (2023). aafp.org
  • Quest Diagnostics. Hair drug testing: frequently asked questions. questdiagnostics.com

Regulatory standards

  • Procedures for Transportation Workplace Drug and Alcohol Testing Programs, 49 C.F.R. Part 40 (see § 40.137, on medical review officer verification of a legitimate medical explanation). ecfr.gov
  • Substance Abuse and Mental Health Services Administration. Mandatory Guidelines for Federal Workplace Drug Testing Programs. samhsa.gov